Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Motomu Hashimoto

Showing results (1-10 of 221) with videos related to

Pageof 23
Sort By:
Journal of Clinical Medicine|July 30, 2017
Th17 in Animal Models of Rheumatoid ArthritisMotomu Hashimoto
Journal of Clinical Medicine|September 28, 2023
Eosinophilic Granulomatosis with Polyangiitis: Latest Findings and Updated Treatment RecommendationsRyu Watanabe, Motomu Hashimoto
Frontiers in Immunology|August 15, 2022
Pathogenic role of monocytes/macrophages in large vessel vasculitisRyu Watanabe, Motomu Hashimoto
Frontiers in Immunology|July 5, 2022
Vasculitogenic T Cells in Large Vessel VasculitisRyu Watanabe, Motomu Hashimoto
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 14, 2009
[Contribution of Th-1, Th-2, Th-17 or regulatory T cells to connective tissue diseases]Motomu Hashimoto, Shimon Sakaguchi
Frontiers in Aging Neuroscience|May 2, 2022
Aging-Related Vascular Inflammation: Giant Cell Arteritis and Neurological DisordersRyu Watanabe, Motomu Hashimoto
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|January 8, 2013
[Role of Th17 cells and innate immunnity for the induction of autoimmune arthritis]Motomu Hashimoto, Tsuneyo Mimori
Frontiers in Immunology|April 18, 2022
Perspectives of JAK Inhibitors for Large Vessel VasculitisRyu Watanabe, Motomu Hashimoto
Frontiers in Medicine|September 1, 2022
Vasculitis associated with VEXAS syndrome: A literature reviewRyu Watanabe, Manami Kiji, Motomu Hashimoto
Arthritis Research & Therapy|November 1, 2022
Comment on "The effect of disease-modifying anti-rheumatic drugs on skeletal muscle mass in rheumatoid arthritis patients: a systematic review with meta-analysis"Hiroto Minamino, Mie Torii, Masao Katsushima, et al.
Pageof 23

Showing results (1-10 of 221) with videos related to

Sort By:
Pageof 23
Journal of Clinical Medicine|July 30, 2017
Th17 in Animal Models of Rheumatoid ArthritisMotomu Hashimoto
Journal of Clinical Medicine|September 28, 2023
Eosinophilic Granulomatosis with Polyangiitis: Latest Findings and Updated Treatment RecommendationsRyu Watanabe, Motomu Hashimoto
Frontiers in Immunology|August 15, 2022
Pathogenic role of monocytes/macrophages in large vessel vasculitisRyu Watanabe, Motomu Hashimoto
Frontiers in Immunology|July 5, 2022
Vasculitogenic T Cells in Large Vessel VasculitisRyu Watanabe, Motomu Hashimoto
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 14, 2009
[Contribution of Th-1, Th-2, Th-17 or regulatory T cells to connective tissue diseases]Motomu Hashimoto, Shimon Sakaguchi
Frontiers in Aging Neuroscience|May 2, 2022
Aging-Related Vascular Inflammation: Giant Cell Arteritis and Neurological DisordersRyu Watanabe, Motomu Hashimoto
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|January 8, 2013
[Role of Th17 cells and innate immunnity for the induction of autoimmune arthritis]Motomu Hashimoto, Tsuneyo Mimori
Frontiers in Immunology|April 18, 2022
Perspectives of JAK Inhibitors for Large Vessel VasculitisRyu Watanabe, Motomu Hashimoto
Frontiers in Medicine|September 1, 2022
Vasculitis associated with VEXAS syndrome: A literature reviewRyu Watanabe, Manami Kiji, Motomu Hashimoto
Arthritis Research & Therapy|November 1, 2022
Comment on "The effect of disease-modifying anti-rheumatic drugs on skeletal muscle mass in rheumatoid arthritis patients: a systematic review with meta-analysis"Hiroto Minamino, Mie Torii, Masao Katsushima, et al.
Pageof 23